<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02834117</url>
  </required_header>
  <id_info>
    <org_study_id>SONTEC</org_study_id>
    <nct_id>NCT02834117</nct_id>
  </id_info>
  <brief_title>Natural Cycle Versus Stimulated Cycle Before Frozen Embryo Transfer</brief_title>
  <acronym>SONTEC</acronym>
  <official_title>Comparison of the Number of Visits and the Quality of Life Versus Natural Cycle in Stimulated Cycle Before Frozen Embryo Transfer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr Massin Nathalie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Intercommunal Creteil</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Embryo freezing is a technique used regularly to optimize the pregnancy rate in case of
      infertility. This method is performed in presence of supernumerary embryo(s) after fresh
      transfer, or after freeze all embryos in case of medical reasons. It is necessary to control
      that the transfer is performed when the endometrium is receptive, which is essential for
      embryo implantation and pregnancy. This period is defined as the &quot;implantation window&quot;.
      Endometrial preparation can be achieved by hormone replacement therapy (HRT) or moderate
      ovarian stimulation (SO). The implantation window can also be assessed by monitoring of a
      natural cycle (NC). The objectives of this open randomized study is to compare the number of
      visits (ultrasound and blood tests) induced by the SO or NC as well as the women quality of
      life in both groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For infertile couples supported by in vitro fertilization, embryo freezing is a technique
      used regularly to optimize the pregnancy rate per retrieval of oocytes. This method is
      performed in case of supernumerary embryo(s) after fresh embryo transfer, or freeze all of
      the embryonic cohort in case of medical reasons preventing the transfer. The embryo or
      embryos can then be thawed and transferred (FET) to achieve a live birth. However, it is
      necessary to first ensure that the transfer is carried out at a time when the endometrium is
      receptive, which is essential for embryo implantation and pregnancy. This period is defined
      as the &quot;implantation window&quot;. Endometrial preparation can be performed by hormone replacement
      therapy (HRT) or moderate ovarian stimulation (SO). The implantation window can also be
      assessed by the monitoring of a natural cycle (NC). The choice of the key moment for the
      transfer is determined by ovulation and / or the rise of progesterone. To date, no study has
      demonstrated the superiority of one protocol over another in terms of birth rates. In the
      investigative center, treatment is usually carried out by daily subcutaneous injections of
      gonadotrophins followed by ovulation induction. In this context, the implementation of the
      FET in natural cycle may appear less burdensome for the patient and more physiological. The
      consideration is additional constraints, NC imposing more frequent monitoring (ultrasound and
      / or hormone assays) to detect the ovulation peak and less freedom in choosing the date of
      transfer. The average number of visits with SO is 2.6 per cycle. The aim of this study is to
      compare the stresses and safety of these two therapeutic proposals to determine the least
      restrictive for patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of visits</measure>
    <time_frame>From inclusion visit to embryo transfer : up to 90 days</time_frame>
    <description>number of visits (for clinical examination, ultrasound and hormonal dosage) required to monitor ovulation in both groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fertiqol</measure>
    <time_frame>From inclusion visit to embryo transfer : up to 90 days</time_frame>
    <description>the score of quality of life related to the couple's infertility, the Fertiqol questionnaire, a questionnaire validated by the European Society of Human Reproduction and Embryology (ESHRE) and taking into account the tolerance to treatment;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>defrost cancellation rate</measure>
    <time_frame>From inclusion visit to embryo transfer : up to 90 days</time_frame>
    <description>the defrost cancellation rate cycle started, whatever the cause: Early ovulation problem of organization, ... excluding &quot;non-transfer&quot; related to embryo lysis thawing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>transfer on weekends and holidays</measure>
    <time_frame>From inclusion visit to embryo transfer : up to 90 days</time_frame>
    <description>the transfer rate on weekends and holidays</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HCG levels&gt; 100 U / L</measure>
    <time_frame>From inclusion visit to pregnancy test : up to 100 days</time_frame>
    <description>the incipient pregnancy rate per transfer defined by a HCG levels&gt; 100 U / L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pregnancy</measure>
    <time_frame>From pregnancy test to ultrasound at 6 week of gestation : up to 100 days</time_frame>
    <description>the rate of pregnancy by ultrasound transfer defined by the presence of a cardiac activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Birth</measure>
    <time_frame>From transfer to delivery : up to 9 months</time_frame>
    <description>The live birth rate per transfer defined by the birth of at least one living child</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gestationnal age at delivery</measure>
    <time_frame>From transfer to delivery : up to 9 months</time_frame>
    <description>the term of delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implantation</measure>
    <time_frame>From transfer to delivery : up to 9 months</time_frame>
    <description>the implantation rate defined by the total number of live births to the total number of embryos replaced</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Miscarriage</measure>
    <time_frame>From pregnancy test to ultrasound at 6 week of gestation : up to 100 days</time_frame>
    <description>the rate of early miscarriage (before 12 SA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost</measure>
    <time_frame>From pregnancy test to ultrasound at 6 week of gestation : up to 100 days</time_frame>
    <description>the average estimated cost of drug treatment and monitoring (ultrasound and hormone assays).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">124</enrollment>
  <condition>Fertility</condition>
  <arm_group>
    <arm_group_label>Natural cycle</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Ovulation is not induced by drugs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate ovarian stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ovulation is induced by recombinant follitropin alpha and recombinant choriogonadotropin</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>natural cycle</intervention_name>
    <description>Ovulation is not induced by drugs</description>
    <arm_group_label>Natural cycle</arm_group_label>
    <other_name>natural</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>moderate ovarian stimulation</intervention_name>
    <description>Ovulation is induced by recombinant follitropin alpha and recombinant choriogonadotropin</description>
    <arm_group_label>Moderate ovarian stimulation</arm_group_label>
    <other_name>ovarian stimulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Affiliation to the general social security regime and benefiting from 100%
             infertility;

          -  Regular Cycles 26 to 35 days;

          -  Support in IVF or ICSI ;

          -  Existence of at least 2 frozen embryos to J2 or J3;

          -  Treated for their first or second cycle of TEC.

        Exclusion Criteria:

          -  Donor sperm;

          -  Irregular cycles and / or polycystic ovary syndrome;

          -  Embryos frozen at J1 or J5 / J6 or double planned transfer or transfer of 3 embryos
             intended;

          -  Patients who have had more than 3 transfers or more than 6 embryos replaced without
             pregnancy or puncture rank&gt; 3;

          -  uterine malformation existing;

          -  Presence of a hydrosalpinx.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nathalie Massin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHIC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maxime Brussieux</last_name>
    <phone>0033157022612</phone>
    <email>m.brussieux.chic@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHI Creteil</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maxime Brussieux</last_name>
    </contact>
    <investigator>
      <last_name>Nathalie Massin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Bjuresten K, Landgren BM, Hovatta O, Stavreus-Evers A. Luteal phase progesterone increases live birth rate after frozen embryo transfer. Fertil Steril. 2011 Feb;95(2):534-7. doi: 10.1016/j.fertnstert.2010.05.019. Epub 2010 Jun 26.</citation>
    <PMID>20579989</PMID>
  </reference>
  <reference>
    <citation>Boivin J, Takefman J, Braverman A. The fertility quality of life (FertiQoL) tool: development and general psychometric properties. Hum Reprod. 2011 Aug;26(8):2084-91. doi: 10.1093/humrep/der171. Epub 2011 Jun 10.</citation>
    <PMID>21665875</PMID>
  </reference>
  <reference>
    <citation>de La Rochebrochard E, Quelen C, Peikrishvili R, Guibert J, Bouyer J. Long-term outcome of parenthood project during in vitro fertilization and after discontinuation of unsuccessful in vitro fertilization. Fertil Steril. 2009 Jul;92(1):149-56. doi: 10.1016/j.fertnstert.2008.05.067. Epub 2008 Aug 15.</citation>
    <PMID>18706550</PMID>
  </reference>
  <reference>
    <citation>Eftekhar M, Rahmani E, Pourmasumi S. Evaluation of clinical factors influencing pregnancy rate in frozen embryo transfer. Iran J Reprod Med. 2014 Jul;12(7):513-8.</citation>
    <PMID>25114675</PMID>
  </reference>
  <reference>
    <citation>El Bahja D, Hertz P, Schweitzer T, Lestrade F, Ragage JP. [Frozen embryo transfer protocol: does spontaneous cycle give good results?]. Gynecol Obstet Fertil. 2013 Nov;41(11):648-52. doi: 10.1016/j.gyobfe.2011.08.007. Epub 2012 Feb 16. French.</citation>
    <PMID>22342107</PMID>
  </reference>
  <reference>
    <citation>Fatemi HM, Kyrou D, Bourgain C, Van den Abbeel E, Griesinger G, Devroey P. Cryopreserved-thawed human embryo transfer: spontaneous natural cycle is superior to human chorionic gonadotropin-induced natural cycle. Fertil Steril. 2010 Nov;94(6):2054-8. doi: 10.1016/j.fertnstert.2009.11.036. Epub 2010 Jan 25.</citation>
    <PMID>20097333</PMID>
  </reference>
  <reference>
    <citation>Groenewoud ER, Cantineau AE, Kollen BJ, Macklon NS, Cohlen BJ. What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis. Hum Reprod Update. 2013 Sep-Oct;19(5):458-70. doi: 10.1093/humupd/dmt030. Epub 2013 Jul 2. Review.</citation>
    <PMID>23820515</PMID>
  </reference>
  <reference>
    <citation>Haouzi D, Assou S, Mahmoud K, Tondeur S, Rème T, Hedon B, De Vos J, Hamamah S. Gene expression profile of human endometrial receptivity: comparison between natural and stimulated cycles for the same patients. Hum Reprod. 2009 Jun;24(6):1436-45. doi: 10.1093/humrep/dep039. Epub 2009 Feb 26.</citation>
    <PMID>19246470</PMID>
  </reference>
  <reference>
    <citation>Nargund G, Wei CC. Successful planned delay of ovulation for one week with indomethacin. J Assist Reprod Genet. 1996 Sep;13(8):683-4.</citation>
    <PMID>8897131</PMID>
  </reference>
  <reference>
    <citation>Park SJ, Goldsmith LT, Skurnick JH, Wojtczuk A, Weiss G. Characteristics of the urinary luteinizing hormone surge in young ovulatory women. Fertil Steril. 2007 Sep;88(3):684-90. Epub 2007 Apr 16.</citation>
    <PMID>17434509</PMID>
  </reference>
  <reference>
    <citation>Tobler KJ, Zhao Y, Weissman A, Majumdar A, Leong M, Shoham Z. Worldwide survey of IVF practices: trigger, retrieval and embryo transfer techniques. Arch Gynecol Obstet. 2014 Sep;290(3):561-8. doi: 10.1007/s00404-014-3232-6. Epub 2014 Apr 18.</citation>
    <PMID>24744054</PMID>
  </reference>
  <reference>
    <citation>Tomás C, Alsbjerg B, Martikainen H, Humaidan P. Pregnancy loss after frozen-embryo transfer--a comparison of three protocols. Fertil Steril. 2012 Nov;98(5):1165-9. doi: 10.1016/j.fertnstert.2012.07.1058. Epub 2012 Jul 27.</citation>
    <PMID>22840239</PMID>
  </reference>
  <reference>
    <citation>Troude P, Guibert J, Bouyer J, de La Rochebrochard E; DAIFI Group. Medical factors associated with early IVF discontinuation. Reprod Biomed Online. 2014 Mar;28(3):321-9. doi: 10.1016/j.rbmo.2013.10.018. Epub 2013 Oct 31.</citation>
    <PMID>24461478</PMID>
  </reference>
  <reference>
    <citation>Weissman A, Levin D, Ravhon A, Eran H, Golan A, Levran D. What is the preferred method for timing natural cycle frozen-thawed embryo transfer? Reprod Biomed Online. 2009 Jul;19(1):66-71.</citation>
    <PMID>19573293</PMID>
  </reference>
  <reference>
    <citation>Yu J, Ma Y, Wu Z, Li Y, Tang L, Li Y, Deng B. Endometrial preparation protocol of the frozen-thawed embryo transfer in patients with polycystic ovary syndrome. Arch Gynecol Obstet. 2015 Jan;291(1):201-11. doi: 10.1007/s00404-014-3396-0. Epub 2014 Jul 31.</citation>
    <PMID>25091221</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 3, 2015</study_first_submitted>
  <study_first_submitted_qc>July 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2016</study_first_posted>
  <last_update_submitted>August 2, 2017</last_update_submitted>
  <last_update_submitted_qc>August 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Intercommunal Creteil</investigator_affiliation>
    <investigator_full_name>Dr Massin Nathalie</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Ovulation Induction</keyword>
  <keyword>quality of life</keyword>
  <keyword>Reproductive Physiological Processes</keyword>
  <keyword>fertility</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

